Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

por Nash, Peter, Ohson, Kamal, Walsh, Jessica, Delev, Nikolay, Nguyen, Dianne, Teng, Lichen, Gómez-Reino, Juan J, Aelion, Jacob A
Publicado 2018

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1–3 pooled analysis

por Kavanaugh, Arthur, Gladman, Dafna D., Edwards, Christopher J., Schett, Georg, Guerette, Benoit, Delev, Nikolay, Teng, Lichen, Paris, Maria, Mease, Philip J.
Publicado 2019

Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study

por Furie, Richard A, Hough, Douglas R, Gaudy, Allison, Ye, Ying, Korish, Shimon, Delev, Nikolay, Weiswasser, Michael, Zhan, Xiaojiang, Schafer, Peter H, Werth, Victoria P
Publicado 2022

Long‐Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials

por Mease, Philip J., Gladman, Dafna D., Gomez‐Reino, Juan J., Hall, Stephen, Kavanaugh, Arthur, Lespessailles, Eric, Schett, Georg, Paris, Maria, Delev, Nikolay, Teng, Lichen, Wollenhaupt, Jürgen
Publicado 2020

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

por Morand, Eric, Pike, Marilyn, Merrill, Joan T., van Vollenhoven, Ronald, Werth, Victoria P., Hobar, Coburn, Delev, Nikolay, Shah, Vaishali, Sharkey, Brian, Wegman, Thomas, Catlett, Ian, Banerjee, Subhashis, Singhal, Shalabh
Publicado 2022

Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies

por Gladman, Dafna D, Kavanaugh, Arthur, Gómez-Reino, Juan J, Wollenhaupt, Jürgen, Cutolo, Maurizio, Schett, Georg, Lespessailles, Eric, Guerette, Benoit, Delev, Nikolay, Teng, Lichen, Edwards, Christopher J, Birbara, Charles A, Mease, Philip J
Publicado 2018

Biological impact of iberdomide in patients with active systemic lupus erythematosus

por Lipsky, Peter E, van Vollenhoven, Ronald, Dörner, Thomas, Werth, Victoria P, Merrill, Joan T, Furie, Richard, Petronijevic, Milan, Velasco Zamora, Benito, Majdan, Maria, Irazoque-Palazuelos, Fedra, Terbrueggen, Robert, Delev, Nikolay, Weiswasser, Michael, Korish, Shimon, Stern, Mark, Hersey, Sarah, Ye, Ying, Gaudy, Allison, Liu, Zhaohui, Gagnon, Robert, Tang, Shaojun, Schafer, Peter H
Publicado 2022